These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36471026)

  • 1. Convolutional Neural Networks Enable Highly Accurate and Automated Subvisible Particulate Classification of Biopharmaceuticals.
    Wang S; Liaw A; Chen YM; Su Y; Skomski D
    Pharm Res; 2023 Jun; 40(6):1447-1457. PubMed ID: 36471026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Three Flow Imaging Microscopy Instruments for Image Analysis in Evaluating four Types of Subvisible Particle in Biopharmaceuticals.
    Nishiumi H; Deiringer N; Krause N; Yoneda S; Torisu T; Menzen T; Friess W; Uchiyama S
    J Pharm Sci; 2022 Nov; 111(11):3017-3028. PubMed ID: 35948157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image Classification of Degraded Polysorbate, Protein and Silicone Oil Sub-Visible Particles Detected by Flow-Imaging Microscopy in Biopharmaceuticals Using a Convolutional Neural Network Model.
    Fedorowicz FM; Chalus P; Kirschenbühler K; Drewes S; Koulov A
    J Pharm Sci; 2023 Dec; 112(12):3099-3108. PubMed ID: 37422283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation, Characterization and Discriminant Analysis of Subvisible Particles in Biologics Formulations.
    Akhunzada ZS; Hubert M; Sahin E; Pratt J
    Curr Pharm Biotechnol; 2019; 20(3):232-244. PubMed ID: 30767738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals.
    Krause N; Kuhn S; Frotscher E; Nikels F; Hawe A; Garidel P; Menzen T
    AAPS J; 2021 Jan; 23(1):13. PubMed ID: 33398482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of subvisible silicone oil droplets from irregular standard dust particles.
    Vandesteeg N; Kilbert C
    J Pharm Sci; 2013 Jun; 102(6):1696-1700. PubMed ID: 23595940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.
    Corvari V; Narhi LO; Spitznagel TM; Afonina N; Cao S; Cash P; Cecchini I; DeFelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Weiskopf A; Wuchner K
    Biologicals; 2015 Nov; 43(6):457-73. PubMed ID: 26324466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards quantification and differentiation of protein aggregates and silicone oil droplets in the low micrometer and submicrometer size range by using oil-immersion flow imaging microscopy and convolutional neural networks.
    Umar M; Krause N; Hawe A; Simmel F; Menzen T
    Eur J Pharm Biopharm; 2021 Dec; 169():97-102. PubMed ID: 34597817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
    Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
    J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator.
    Patel AR; Lau D; Liu J
    Anal Chem; 2012 Aug; 84(15):6833-40. PubMed ID: 22794526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging.
    Sharma DK; Oma P; Pollo MJ; Sukumar M
    J Pharm Sci; 2010 Jun; 99(6):2628-42. PubMed ID: 20049937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles.
    Calderon CP; Krhač Levačić A; Helbig C; Wuchner K; Menzen T
    J Pharm Sci; 2022 Sep; 111(9):2422-2434. PubMed ID: 35661758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Particles in Biopharmaceutical Products.
    Saggu M; Bou-Assaf GM; Bucher R; Budyak IL; Buecheler J; Cao S; Groenning M; Khan E; Kwok SC; Minocha S; Pisupati K; Radhakrishnan V; Videbæk N; Yang DT; Zhang B; Narhi LO
    J Pharm Sci; 2024 May; 113(5):1401-1414. PubMed ID: 38220088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Evaluation of Two Methods for Preparative Fractionation of Proteinaceous Subvisible Particles--Differential Centrifugation and FACS.
    Boll B; Folzer E; Finkler C; Huwyler J; Mahler HC; Schmidt R; Koulov AV
    Pharm Res; 2015 Dec; 32(12):3952-64. PubMed ID: 26195006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Flow Cytometry for Sizing and Counting of Subvisible Particles in Biotherapeutics.
    Helbig C; Menzen T; Wuchner K; Hawe A
    J Pharm Sci; 2022 Sep; 111(9):2458-2470. PubMed ID: 35777484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and Uncertainty Analysis of Micro-Flow Imaging for Sub-Visible Particle Measurements Using Artificial Neural Network.
    Poozesh S; Cannavò F; Manikwar P
    Pharm Res; 2023 Mar; 40(3):721-733. PubMed ID: 36697932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Differentiation of Protein Aggregates From Other Subvisible Particles in Viscous Mixtures Through Holographic Characterization.
    Winters A; Cheong FC; Odete MA; Lumer J; Ruffner DB; Mishra KI; Grier DG; Philips LA
    J Pharm Sci; 2020 Aug; 109(8):2405-2412. PubMed ID: 32439328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning approaches to root cause analysis, characterization, and monitoring of subvisible particles in monoclonal antibody formulations.
    Greenblott DN; Zhang J; Calderon CP; Randolph TW
    Biotechnol Bioeng; 2022 Dec; 119(12):3596-3611. PubMed ID: 36124935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro-Flow Imaging: Estimation of the Contribution of Key Factors to the Variability of Subvisible Particle Count Measurement by a Nested Statistical Analysis.
    Zhang K; Wrzosek T; Desai KG; Monck M
    PDA J Pharm Sci Technol; 2020; 74(1):15-26. PubMed ID: 31519785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Convolutional Neural Network Analysis of Flow Imaging Microscopy Data to Classify Subvisible Particles in Protein Formulations.
    Calderon CP; Daniels AL; Randolph TW
    J Pharm Sci; 2018 Apr; 107(4):999-1008. PubMed ID: 29269269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.